Podcasts Other Catalog of Interviews and Bits Louis DeGennaro, PhD, president and CEO of LLS is available to discuss how the organization is continuing its commitment to blood cancer patients through its recently launched LLS COVID-19 Patient Aid Financial Program, which launched with $5 million last week, in conjunction with LLS partners including Walgreens, Suba

Louis DeGennaro, PhD, president and CEO of LLS is available to discuss how the organization is continuing its commitment to blood cancer patients through its recently launched LLS COVID-19 Patient Aid Financial Program, which launched with $5 million last week, in conjunction with LLS partners including Walgreens, Suba

Published: Aug. 5, 2020, 9:18 p.m.

Louis DeGennaro, PhD, president and CEO of LLS is available to discuss how the organization is continuing its commitment to blood cancer patients through its recently launched LLS COVID-19 Patient Aid Financial Program, which launched with $5 million last week, in conjunction with LLS partners including Walgreens, Subaru and Burlington, is providing $250 each to eligible blood cancer patients to assist with non-medical expenses. LLS also provides free support services to patients and caregivers, including personalized, one-on-one phone and online support with medical professionals. LLS is a global leader in the fight against cancer. Dr. DeGennaro can also discuss how LLS is advancing cutting edge cancer research to advance new treatments and cures, as well as its advocacy in Washington, DC, to break down barriers so patients have access to lifesaving care.